Oxford Pharmaceuticals, a generic-drug company, has broken ground for a new $29.4 million pharmaceutical manufacturing plant in Birmingham, Alabama. The 120,000-square-foot facility is being built on 23.4 acres in the Jefferson Metropolitan Park-Lakeshore and is expected to be operating in the third quarter of 2016.

Oxford Pharmaceuticals, a new venture formed in Oxford, England, will produce, package, and research generic drugs at the Alabama plant. The project will initially create 61 jobs, but that figure is projected to grow to 200 within 10 years. The company has said it has room for further expansion.

Source: Alabama Department of Commerce